Stock Splits
By The Online Investor Staff, updated Fri., May. 24, 7:04 AM
| This Slide: #1 of 25 |
Slide #1. OncoSec Medical Incorporated (NASDAQ:ONCS) — 1 for 10 Reverse Split
Announced:
5/20/2019
Stock Split:
1 for 10
Record Date:
5/20/2019
Pay Date:
5/21/2019
ONCS Optionable?:
No
OncoSec Medical is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. Co.'s primary platform technology, ImmunoPulse®, is a drug-device therapeutic modality comprised of a proprietary intratumoral electroporation delivery device. The ImmunoPulse® platform is designed to deliver DNA-encoded drugs directly into a solid tumor and promote an inflammatory response against cancer. Co.'s main product candidate, ImmunoPulse® IL-12, uses Co.'s electroporation device to deliver a DNA-encoded interleukin-12 (IL-12), called tavokinogene telseplasmid. 
ONCS Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the ONCS Page at The Online Investor (in a new window) »
List of Stock Splits in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable TROV 1 for 6 2/19/2019 2/19/2019 2/20/2019 No MLNT 1 for 5 2/21/2019 2/21/2019 2/22/2019 Yes XSPA 1 for 20 2/22/2019 2/22/2019 2/25/2019 Yes RBZ 1 for 8 3/14/2019 3/14/2019 3/15/2019 No OTLK 1 for 8 3/15/2019 3/15/2019 3/18/2019 No ATIS 1 for 8 3/15/2019 3/15/2019 3/18/2019 No CRMD 1 for 5 3/25/2019 3/25/2019 3/26/2019 Yes NSPR 1 for 50 3/26/2019 3/29/2019 4/1/2019 No HOV 1 for 25 3/29/2019 3/29/2019 3/29/2019 Yes MARA 4 for 1 4/5/2019 4/5/2019 4/8/2019 Yes MOXC 1 for 5 4/5/2019 4/19/2019 4/22/2019 No RNN 1 for 12 4/10/2019 4/12/2019 4/12/2019 Yes BPMX 1 for 25 4/15/2019 4/25/2019 4/26/2019 No FAST 2 for 1 4/18/2019 5/2/2019 5/22/2019 Yes ARCI 1 for 5 4/18/2019 4/19/2019 4/22/2019 No DAC 1 for 14 4/22/2019 5/1/2019 5/2/2019 No FFIN 2 for 1 4/23/2019 6/17/2019 7/1/2019 Yes NMM 1 for 15 4/25/2019 5/21/2019 5/21/2019 Yes EARS 1 for 20 4/30/2019 4/30/2019 5/1/2019 No DMPI 1 for 10 5/7/2019 5/7/2019 5/8/2019 No FCEL 1 for 12 5/8/2019 5/8/2019 5/9/2019 Yes NVAX 1 for 20 5/8/2019 5/10/2019 5/10/2019 Yes VISL 1 for 10 5/10/2019 5/10/2019 5/13/2019 No VLRX 1 for 20 5/17/2019 5/17/2019 5/20/2019 No ONCS 1 for 10 5/20/2019 5/20/2019 5/21/2019 No
|
|
Avg. Broker Rec.
|
Buy (3.00 out of 4) 36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
